Sign up to save your podcasts
Or
Share 124: Mostafa Kamal Talks Prime Therapeutics, Magellan Rx Integration, the Organizations Trajectory, More
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
124: Mostafa Kamal Talks Prime Therapeutics, Magellan Rx Integration, the Organizations Trajectory, More
Managed Healthcare Executive's Managing Editor Peter Wehrwein, and Editor Briana Contreras, had a discussion in July with Mostafa Kamal, president and CEO of Prime Therapeutics, an organization in which Kamal acquired this position in July 2023. Kamal addressed his newer role, plans for Prime, the company’s more recent acquisitions and previous partnerships and some of his thoughts on the multimillion gene therapies and price transparency from a PBM perspective.
View all episodes
By Tuning Into The C-Suite
5
22 ratings
Managed Healthcare Executive's Managing Editor Peter Wehrwein, and Editor Briana Contreras, had a discussion in July with Mostafa Kamal, president and CEO of Prime Therapeutics, an organization in which Kamal acquired this position in July 2023. Kamal addressed his newer role, plans for Prime, the company’s more recent acquisitions and previous partnerships and some of his thoughts on the multimillion gene therapies and price transparency from a PBM perspective.